Prelamin A is farnesylated and methylated on the cysteine residue of a carb
oxyl-terminal CaaX motif, In the nucleus, prelamin A is processed to lamin
A by endoproteolytic removal of the final 18 amino acids, including the far
nesylated cysteine residue, Using the yeast two-hybrid assay, we isolated a
novel human protein, Narf, that binds the carboxyl-terminal tail of prelam
in A. Narf has limited homology to iron-only bacterial hydrogenases and euk
aryotic proteins of unknown function. Narf is encoded by a 2-kilobase mRNA
expressed in all human cell lines and tissues examined. The protein is dete
cted in the nuclear fraction of HeLa cell lysates on Western blots and can
be extracted from nuclear envelopes with 0.5 M NaCl. When a FLAG epitope-ta
gged Narf is expressed in HeLa cells, it is exclusively nuclear and partial
ly co-localizes with the nuclear lamina, The farnesylation status of prelam
in A determines its ability to bind to Narf. Inhibition of farnesyltransfer
ase and mutation or deletion of the CaaX motif from the prelamin A tail dom
ain inhibits Narf binding in yeast two-hybrid and in vitro binding assays.
The prenyl-dependent binding of Narf to prelamin A is an important first st
ep in understanding the functional significance of the lamin A precursor.